Learn About Pulmonary Fibrosis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Mcv Associated Physicians
Patricia Sime is a Pulmonary Medicine provider in Richmond, Virginia. Dr. Sime and is rated as an Elite provider by MediFind in the treatment of Pulmonary Fibrosis. Her top areas of expertise are Pulmonary Fibrosis, Pneumonia, Idiopathic Pulmonary Fibrosis, and Acute Interstitial Pneumonia. Dr. Sime is currently accepting new patients.
Inova Health Care Services
Steven Nathan is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Falls Church, Virginia. Dr. Nathan has been practicing medicine for over 44 years and is rated as an Elite provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Lung Transplant, and Heart Transplant. Dr. Nathan is currently accepting new patients.
USC Care Medical Group Inc
Toby Maher is a Pulmonary Medicine provider in Los Angeles, California. Dr. Maher and is rated as an Elite provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Lung Transplant, and Tissue Biopsy.
Summary: The ASPIRE trial is a 52 week randomized, double-blind, placebo-controlled, parallel-group, multicenter trial in which the efficacy, safety, and pharmacokinetics of orally administered buloxibutid, either on top of stable IPF therapy or as monotherapy, are assessed in participants with IPF. Trial website: www.aspire-ipf.com
Summary: Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period.